United States · Markets & Finance · Yahoo Finance

Orion Pharma announces agreement with Qilu Pharma Europe for pembrolizumab biosimilar for European market

Published by Yahoo Finance · United States 9 h ago

ORION CORPORATION PRESS RELEASE 6 OCTOBER 2026 at 9.00 EEST Orion Pharma announces agreement with Qilu Pharma Europe for pembrolizumab biosimilar for European market Orion…

Read the full article on Yahoo Finance Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (finance.yahoo.com)

Also worth reading

Business Insider

What is Beam? The buzzy American AI model being called the 'DeepSeek of the West'

NYT Business

U.S. scraps proposed $10,000 reporting rule for for crypto sent to private wallets

Fortune

Orion Pharma announces agreement with Qilu Pharma Europe for pembrolizumab biosimilar for European market

Share

Also worth reading

What is Beam? The buzzy American AI model being called the 'DeepSeek of the West'

South Korea Investigates Possible Use of A.I. in Hacks on Its Banks

Here’s what happened in crypto today

How quant funds beat the market by being 'early, contrarian and right'

U.S. scraps proposed $10,000 reporting rule for for crypto sent to private wallets

OKX debuts a platform that turns 50 currencies into digital dollars, betting emerging market investors want stablecoins